- Eagle Pharmaceuticals (NASDAQ:EGRX): FQ4 EPS of -$0.65 misses by $0.16.
- Revenue of $2.81M (-39.4% Y/Y) beats by $0.08M.
- Press Release
Eagle Pharmaceuticals misses by $0.16, beats on revenue
Recommended For You
More Trending News
About EGRX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| EGRX | - | - |
| Eagle Pharmaceuticals, Inc. | ||